Analyst Ratings for Cardiome Pharma (CRME)

CRME Rating Summary

  |   Expand Research on CRME
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 8 / 10   Percentile Rank: 77%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/15/2017 Mackie Research N/A Upgrade Spec. Buy
(Hold)		 2.80
(2.00)		 1.43
(2.33)		 62.94% Details
7/17/2017 Canaccord
» Updated 11/15/2017		 N/A New Coverage Buy
(N/A)		 5.00
(8.00)		 4.70
(2.33)		 -50.43% Details